Tofacitinib
ATC L04AF01 · 10 markets · 203 records
CN 88 records · 2 strengths
- 5 mgtablet尚杰枸橼酸托法替布__mah__:上海上药中西制药有限公司、__mah__:先声药业有限公司、__mah__:华润赛科药业有限责任公司、__mah__:南京正大天晴制药有限公司、__mah__:复星万邦(江苏)医药集团有限公司、__mah__:天地恒一制药股份有限公司、__mah__:宏越科技(湖州)有限公司、__mah__:山东新华制药股份有限公司 +23
- 11 mgtablet · extended-releaseManufacturer: Pfizer Inc. ×2__mah__:上海宣泰医药科技股份有限公司、__mah__:乐普制药科技有限公司、__mah__:四川科伦药业股份有限公司、__mah__:宜昌人福药业有限责任公司、__mah__:成都康弘药业集团股份有限公司、__mah__:石药集团欧意药业有限公司、__mah__:齐鲁制药有限公司
US 60 records · 7 strengths
- 5 mgtabletTofacitinibXELJANZ、__no_trade__
- 11 mgtablet · extended-releaseTofacitinibXELJANZ、__no_trade__
- 10 mgtabletTofacitinibXELJANZ、__no_trade__
- 1 mgliquidTofacitinibXELJANZ、__no_trade__
- 22 mgtablet · extended-releaseXELJANZ__no_trade__
- 16.16 mgtabletNo trade name
- 8.08 mgtabletNo trade name
CA 16 records · 3 strengths
- 5 mgtabletAPO-TOFACITINIBAURO-TOFACITINIB、DEVATIS TOFACITINIB、JAMP TOFACITINIB、PMS-TOFACITINIB、SANDOZ TOFACITINIB、TARO-TOFACITINIB、XELJANZ
- 11 mgtablet · extended-releaseTARO-TOFACITINIBXELJANZ
- 10 mgtabletAPO-TOFACITINIBAURO-TOFACITINIB、DEVATIS TOFACITINIB、SANDOZ TOFACITINIB、TARO-TOFACITINIB、XELJANZ
TW 6 records · 5 strengths
- 5 mgtabletXELJANZ捷抑炎 膜衣錠 5毫克
- 11 mgtablet · extended-releaseJakop Extended-Release Tablets 22 mgXeljanz XR Extended Release Tablets 11 mg、捷抑炎持續性藥效錠11毫克、舒適捷持續性藥效錠11毫克
- 10 mgtabletXELJANZ捷抑炎膜衣錠10毫克
- 1 mgliquidXeljanz 1mg/ml oral solution捷抑炎口服液1毫克/毫升
- 22 mgtablet · extended-releaseJakop Extended-Release Tablets 22 mg傑可普持續性藥效錠22毫克
GB 5 records · 4 strengths
- 5 mgtabletXELJANZ__no_trade__
- 11 mgtablet · extended-releaseXeljanz 11mg modified-release tablets
- 10 mgtabletXELJANZ
- 1 mgliquidXeljanz 1mg/ml oral solution
AU 4 records · 4 strengths
Records without a stated strength · 1 XELJANZ
ES 4 records · 4 strengths
MX 4 records · 2 strengths
- 5 mgtabletBEVATTALIAFAX、TOFATEC
Records without a stated strength · 1 XELJANZ
HK 4 records · 1 strengths
Records without a stated strength · 1 XELJANZ、Xeljanz 1mg/ml oral solution、Xeljanz XR Extended Release Tablets 11 mg
EU 2 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 XELJANZ、Xeljanz (Refusal)
| Strength / form / release | US | GB | CA | AU | CN | ES | MX | TW | HK | EU |
|---|---|---|---|---|---|---|---|---|---|---|
| 5 mg tablet | No trade name Tofacitinib XELJANZ | No trade name XELJANZ | APO-TOFACITINIB AURO-TOFACITINIB DEVATIS TOFACITINIB+5JAMP TOFACITINIB PMS-TOFACITINIB SANDOZ TOFACITINIB TARO-TOFACITINIB XELJANZ | XELJANZ | Manufacturer: 上海上药中西制药有限公司 Manufacturer: 先声药业有限公司 Manufacturer: 华润赛科药业有限责任公司+29Manufacturer: 南京正大天晴制药有限公司 Manufacturer: 复星万邦(江苏)医药集团有限公司 ×4 Manufacturer: 天地恒一制药股份有限公司 Manufacturer: 宏越科技(湖州)有限公司 ×2 Manufacturer: 山东新华制药股份有限公司 ×2 Manufacturer: 山东新时代药业有限公司 ×6 Manufacturer: 山东鲁抗三叶制药有限公司 Manufacturer: 山东鲁抗医药股份有限公司 ×2 Manufacturer: 成都倍特药业股份有限公司 Manufacturer: 扬子江药业集团江苏紫龙药业有限公司 Manufacturer: 杭州博之锐生物制药有限公司 Manufacturer: 正大天晴药业集团南京顺欣制药有限公司 ×9 Manufacturer: 江苏康倍得药业股份有限公司 Manufacturer: 江苏正大清江制药有限公司 ×3 Manufacturer: 江西心正药业有限责任公司 Manufacturer: 河北万岁药业有限公司 Manufacturer: 浙江三生蔓迪药业有限公司 Manufacturer: 浙江华海药业股份有限公司 ×5 Manufacturer: 湖南九典制药股份有限公司 ×3 Manufacturer: 湖南科伦制药有限公司 ×5 Manufacturer: 石药集团欧意药业有限公司 ×4 Manufacturer: 福安药业集团宁波天衡制药有限公司 ×3 Manufacturer: 西洲医药科技(浙江)有限公司 Manufacturer: 重庆医药(集团)股份有限公司 ×3 Manufacturer: 重庆药友制药有限责任公司 Manufacturer: 马应龙药业集团股份有限公司 Manufacturer: 黑龙江珍宝岛药业股份有限公司 ×2 Manufacturer: 齐鲁制药有限公司 ×2 尚杰枸橼酸托法替布 | XELJANZ | BEVAT TALIAFAX TOFATEC | XELJANZ 捷抑炎 膜衣錠 5毫克 | ||
| 11 mg tablet · extended-release | No trade name Tofacitinib XELJANZ | Xeljanz 11mg modified-release tablets | TARO-TOFACITINIB XELJANZ | Manufacturer: Pfizer Inc. ×2 Manufacturer: 上海宣泰医药科技股份有限公司 ×4 Manufacturer: 乐普制药科技有限公司+5Manufacturer: 四川科伦药业股份有限公司 ×3 Manufacturer: 宜昌人福药业有限责任公司 Manufacturer: 成都康弘药业集团股份有限公司 ×4 Manufacturer: 石药集团欧意药业有限公司 ×4 Manufacturer: 齐鲁制药有限公司 ×2 | XELJANZ | Jakop Extended-Release Tablets 22 mg Xeljanz XR Extended Release Tablets 11 mg 捷抑炎持續性藥效錠11毫克 | ||||
| 10 mg tablet | No trade name Tofacitinib XELJANZ | XELJANZ | APO-TOFACITINIB AURO-TOFACITINIB DEVATIS TOFACITINIB | XELJANZ | XELJANZ | XELJANZ 捷抑炎膜衣錠10毫克 | ||||
| 1 mg liquid | No trade name Tofacitinib XELJANZ | Xeljanz 1mg/ml oral solution | Xeljanz 1mg/ml oral solution 捷抑炎口服液1毫克/毫升 | |||||||
| 22 mg tablet · extended-release | No trade name XELJANZ | Jakop Extended-Release Tablets 22 mg 傑可普持續性藥效錠22毫克 | ||||||||
| 1 mg/1 mL liquid | XELJANZ | XELJANZ | ||||||||
| 16.16 mg tablet | No trade name | |||||||||
| 8.08 mg tablet | No trade name | |||||||||
unknown | XELJANZ | XELJANZ Xeljanz 1mg/ml oral solution Xeljanz XR Extended Release Tablets 11 mg | XELJANZ Xeljanz (Refusal) | |||||||
liquid | XELJANZ |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
3 more strength/form rows are recorded only in AU · ES · MX · HK · EU and are not shown in this table. Hay 3 filas de concentración/forma registradas solo en AU · ES · MX · HK · EU que no se muestran en esta tabla. 另有 3 个规格/剂型仅在 AU · ES · MX · HK · EU 有记录(未在本表显示)。 另有 3 個規格/劑型僅在 AU · ES · MX · HK · EU 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.